HPV

School Programme 2017/2018

 

The Schools Immunisation Programme (SIP) is developed in accordance with the guidance issued by the National Immunisation Advisory Committee (NIAC) of the Royal College of Physicians of Ireland (RCPI) and contained in the Immunisation Guidelines for Ireland.

In Ireland, all the recommended childhood vaccines given in the schools immunisation programme are free.

HPV Programme

The programme aims to vaccinate on an annual basis all 12 to 13 year old girls with HPV by targeting girls in first year in second level schools and age equivalent (for 2017/2018 academic year girls born between 01/09/2005 and 31/08/2006) in special schools and home schooled students.

Information materials for parents are available in the HPV school section

HPV Vaccine safety and Effectiveness

Since HPV vaccine was licensed in 2006 research has been conducted all over the world that demonstrates that the vaccine is safe and prevents cancer. The evidence has been steadily growing since 2006 and now an enormous bank of research exists which proves the safety and effectiveness of this vaccine. This heat map shows the countries which have conducted most research on HPV vaccine however, studies have been conducted worldwide which confirm that HPV vaccination is the right way to protect girls from cervical cancer.

Click here to read more about the research.

HPVgraphic

To read more about HPV please visit the following pages

The HPV Programme for 2017/2018 was launched on Wednesday 30th August 2017. The presentations from the day are available below

An audit of HPV information materials from 7 countries was recently carried out. The results are available to download here.

The following information materials are available for healthcare professionals carrying out this programme.

Please note you will be leaving www.immunisation.ie when you click the SPC and PIL links

More Information about HPV can be found at the following websites:

Gardasil safety reports

In January 2017 all 69 US National Cancer Institute NCI-designated Cancer Centers Endorsed HPV Vaccination

As national leaders in cancer research and clinical care, we are compelled to collectively call upon parents and health care providers to increase vaccination rates so our nation’s children don’t grow up to become cancer patients.

HPV vaccines, like all vaccines (used in the U.S.), have passed extensive safety testing before and after being approved.

The vaccines  have a safety profile similar to that of other vaccines approved for adolescents in the U.S.

Internationally, the safety of HPV vaccines has been tested and approved by the World Health Organization’s Global Advisory Committee on Vaccine Safety”.

See information at https://www.ucdmc.ucdavis.edu/news/images/pdf/HPVConsensusStatement_Jan2017.pdf

This page was updated on 26 October 2017